77 related articles for article (PubMed ID: 20514850)
21. Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.
Tidefelt U; Elmhorn-Rosenborg A; Paul C; Hao XY; Mannervik B; Eriksson LC
Cancer Res; 1992 Jun; 52(12):3281-5. PubMed ID: 1596886
[TBL] [Abstract][Full Text] [Related]
22. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
[TBL] [Abstract][Full Text] [Related]
23. Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.
Bonavida B
Oncogene; 2007 May; 26(25):3629-36. PubMed ID: 17530016
[TBL] [Abstract][Full Text] [Related]
24. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
25. The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia: induction of cell death via the triggering of multiple signalling pathways.
Hallak M; Win T; Shpilberg O; Bittner S; Granot Y; Levy I; Nathan I
Br J Haematol; 2009 Nov; 147(4):459-70. PubMed ID: 19747367
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
27. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
[TBL] [Abstract][Full Text] [Related]
28. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
[TBL] [Abstract][Full Text] [Related]
30. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
[TBL] [Abstract][Full Text] [Related]
31. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
32. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
Uckun FM; Qazi S; Ozer Z; Garner AL; Pitt J; Ma H; Janda KD
Br J Haematol; 2011 Jun; 153(6):741-52. PubMed ID: 21517817
[TBL] [Abstract][Full Text] [Related]
33. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
[TBL] [Abstract][Full Text] [Related]
34. Molecular targeted therapies for rhabdomyosarcoma: focus on hedgehog and apoptosis signaling.
Fulda S
Klin Padiatr; 2013 May; 225(3):115-9. PubMed ID: 23625685
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
[TBL] [Abstract][Full Text] [Related]
36. Baseline serum levels of multiple cytokines and adhesion molecules in patients with acute myeloid leukemia: results of a pivotal trial.
Kupsa T; Vasatova M; Karesova I; Zak P; Horacek JM
Exp Oncol; 2014 Dec; 36(4):252-7. PubMed ID: 25537219
[TBL] [Abstract][Full Text] [Related]
37. Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML.
Rosen DB; Cordeiro JA; Cohen A; Lacayo N; Hogge D; Hawtin RE; Cesano A
Leuk Res; 2012 Jul; 36(7):900-4. PubMed ID: 22521550
[TBL] [Abstract][Full Text] [Related]
38. [Key molecular mechanisms associated with cell malignant transformation in acute myeloid leukemia].
Orlova NN; Lebedev TD; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2016; 50(3):395-405. PubMed ID: 27414778
[TBL] [Abstract][Full Text] [Related]
39. [A study on relationship between chemotherapy of acute leukemia and apoptosis in vivo].
Cen X; Zhu P; Yu J
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):300-3. PubMed ID: 10374269
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML.
Modarres P; Mohamadi Farsani F; Nekouie AA; Vallian S
Sci Rep; 2021 Jun; 11(1):12485. PubMed ID: 34127725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
